Heather Irving
Family · Arkansas City, KSNPI 1598199770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $799 and has fallen 54.9% since, to $360 in 2025.
Across 115 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$228
- AstraZeneca$218
- Amgen$208
- Lilly USA, LLC$201
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$188
- Sanofi-aventis U.S. LLC$122
- plus $794 from 20 others
What the payments were for
- Food & beverage$1,959100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $228 |
| AstraZeneca | 12 | $218 |
| Amgen | 7 | $208 |
| Lilly USA, LLC | 16 | $201 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $188 |
| Sanofi-aventis U.S. LLC | 8 | $122 |
| Boehringer Ingelheim | 7 | $110 |
| Novo Nordisk | 6 | $110 |
| Pfizer | 7 | $99 |
| Merck | 7 | $96 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Lundbeck LLC | 2 | $38 |
| Edwards Lifesciences | 2 | $34 |
| Abbott | 2 | $32 |
| Smith+Nephew | 1 | $30 |
| Bioventus LLC | 1 | $26 |
| Baxter Healthcare | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Novartis | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kyprolis$119
How this compares
$1,959 in reported general payments places this provider in the 85th percentile of 1,579 family providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 23 | $152 |
| Levothyroxine Sodium | 23 | $95 |
| Amlodipine Besylate | 22 | $75 |
| Lisinopril | 19 | $66 |
| Metoprolol Succinate | 13 | $59 |
| Metformin Hcl | 14 | $20 |
Paid to pharmacies, not to this prescriber.
Other family in Arkansas City
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
- Adam CaseKansas City$34K
- Jaimie HeldstabWestwood$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.